Linden Thomas Advisory Services’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
5,072
+140
| +3% | +$30.6K | 0.12% | 260 |
|
|
2025
Q1 | $1.1M | Buy |
4,932
+293
| +6% | +$65.6K | 0.14% | 259 |
|
|
2024
Q4 | $1.52M | Buy |
4,639
+351
| +8% | +$115K | 0.19% | 190 |
|
|
2024
Q3 | $1.29M | Buy |
4,288
+233
| +6% | +$69.9K | 0.18% | 229 |
|
|
2024
Q2 | $1.34M | Buy |
4,055
+1,322
| +48% | +$435K | 0.21% | 209 |
|
|
2024
Q1 | $1.08M | Buy |
2,733
+235
| +9% | +$93K | 0.17% | 245 |
|
|
2023
Q4 | $880K | Buy |
2,498
+261
| +12% | +$91.9K | 0.16% | 256 |
|
|
2023
Q3 | $839K | Buy |
2,237
+99
| +5% | +$37.1K | 0.19% | 231 |
|
|
2023
Q2 | $818K | Buy |
2,138
+171
| +9% | +$65.4K | 0.18% | 229 |
|
|
2023
Q1 | $682K | Sell |
1,967
-18
| -0.9% | -$6.24K | 0.17% | 239 |
|
|
2022
Q4 | $467K | Buy |
+1,985
| New | +$467K | 0.13% | 254 |
|